Skip to content
HealthMinute.TV

HealthMinute.TV

  • Home
  • Derm.City
  • Derm.Business
  • Chronicle Companies
  • Contact

Author: chroniclepublishing

October 30, 2024October 31, 2024 chroniclepublishing Skin Care

Cosmetic regimen effectively treats skin redness in rosacea

According to a recent study, a cosmetic regimen of a treatment serum, redness-reducing moisturizer, and sunscreen was effective in reducing redness and improving skin appearance.

October 24, 2024 chroniclepublishing Skin Care

Study shows ferulic acid effective as adjuvant treatment for papulopustular rosacea

According to a recent study, topical ferulic acid is effective as an adjuvant treatment for papulopustular rosacea.

October 16, 2024October 17, 2024 chroniclepublishing psoriasis

New study links stress and psoriasis relapse

According to a recent study, perceived stress can trigger the relapse of psoriatic skin lesions. The study was presented at the European Academy of Dermatology and Venereology Congress in Amsterdam (Sept. 27, 2024).

October 10, 2024 chroniclepublishing psoriasis

Home-based narrowband UV-B phototherapy for PsO as effective as office-based treatment

According to a recent study, home-based narrowband UV-B phototherapy for plaque and guttate psoriasis is as effective as office-based treatments.

October 2, 2024 chroniclepublishing Skin Care

Exclusive content available for ISSS and SSS attendees

The Indigenous Skin Spectrum Summit will be held on Friday, Oct. 4, followed by the Skin Spectrum Summit on Saturday, Oct. 5.

September 25, 2024September 26, 2024 chroniclepublishing psoriasis

Veterans are more at risk for psoriasis, skin cancer

According to a recent study, U.S. veterans are more likely to have a history of skin cancer, melanoma, and psoriasis when compared to non-veterans.

September 18, 2024September 19, 2024 chroniclepublishing atopic dermatitis

Risk of pediatric AD associated with childhood obesity

According to a recent study, risk of pediatric atopic dermatitis (AD) is associated with childhood obesity and correlated to weight loss and gain.

September 12, 2024 chroniclepublishing psoriasis

Extended guselkumab dosing effective for PsO super responders

According to a recent study, extending the dosing interval of guselkumab from eight weeks to sixteen weeks is non-inferior for treating moderate-to-severe psoriasis in super-responders.

September 4, 2024September 5, 2024 chroniclepublishing atopic dermatitis

Cendakimab safe, efficacious in treating moderate-to-severe AD

According to a recent study, cendakimab is safe and efficacious in treating moderate-to-severe atopic dermatitis (AD) in adult patients.

August 29, 2024 chroniclepublishing psoriasis

PsO disease severity linked to missed work days

According to a recent study, patients with moderate-to-severe psoriasis are more than twice as likely to take a half-day off work than those with mild psoriasis.

Posts navigation

Older posts
Newer posts
Create a website or blog at WordPress.com
HealthMinute.TV
Create a website or blog at WordPress.com
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
  • Subscribe Subscribed
    • HealthMinute.TV
    • Join 63 other subscribers
    • Already have a WordPress.com account? Log in now.
    • HealthMinute.TV
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...
 

    Design a site like this with WordPress.com
    Get started